Literature DB >> 34788828

Genomic Characterization of Group A Streptococci Causing Pharyngitis and Invasive Disease in Colorado, USA, June 2016- April 2017.

Yuan Li1, Samuel Dominguez2,3, Srinivas A Nanduri1, Joy Rivers1, Saundra Mathis1, Zhongya Li1, Lesley McGee1, Sopio Chochua1, Benjamin J Metcalf1, Chris A Van Beneden1, Bernard Beall1, Lisa Miller4.   

Abstract

BACKGROUND: The genomic features and transmission link of circulating Group A Streptococcus (GAS) strains causing different disease types, such as pharyngitis and invasive disease, are not well understood.
METHODS: We used whole-genome sequencing to characterize GAS isolates recovered from persons with pharyngitis and invasive disease in the Denver metropolitan area from June 2016 to April 2017.
RESULTS: The GAS isolates were cultured from 236 invasive and 417 pharyngitis infections. Whole-genome sequencing identified 34 emm types. Compared with pharyngitis isolates, invasive isolates were more likely to carry the erm family genes (23% vs 7.4%, P<.001), which confer resistance to erythromycin and clindamycin (including inducible resistance), and covS gene inactivation (7% vs 0.5%, P<.001). Whole-genome sequencing identified 97 genomic clusters (433 isolates; 2-65 isolates per cluster) that consisted of genomically closely related isolates (median single-nucleotide polymorphism=3 [interquartile range, 1-4] within cluster). Thirty genomic clusters (200 isolates; 31% of all isolates) contained both pharyngitis and invasive isolates and were found in 11 emm types.
CONCLUSIONS: In the Denver metropolitan population, mixed disease types were commonly seen in clusters of closely related isolates, indicative of overlapping transmission networks. Antibiotic-resistance and covS inactivation was disproportionally associated with invasive disease. Published by Oxford University Press for the Infectious Diseases Society of America 2021.

Entities:  

Keywords:  Group A streptococcus; antimicrobial resistance; genomic cluster; invasive disease; pharyngitis

Mesh:

Substances:

Year:  2022        PMID: 34788828      PMCID: PMC9125432          DOI: 10.1093/infdis/jiab565

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  37 in total

Review 1.  Tissue tropisms in group A streptococcal infections.

Authors:  Debra E Bessen; Sergio Lizano
Journal:  Future Microbiol       Date:  2010-04       Impact factor: 3.165

2.  Holiday spikes in pneumococcal disease among older adults.

Authors:  Nicholas D Walter; Thomas H Taylor; Scott F Dowell; Saundra Mathis; Matthew R Moore
Journal:  N Engl J Med       Date:  2009-12-24       Impact factor: 91.245

3.  Molecular complexity of successive bacterial epidemics deconvoluted by comparative pathogenomics.

Authors:  Stephen B Beres; Ronan K Carroll; Patrick R Shea; Izabela Sitkiewicz; Juan Carlos Martinez-Gutierrez; Donald E Low; Allison McGeer; Barbara M Willey; Karen Green; Gregory J Tyrrell; Thomas D Goldman; Michael Feldgarden; Bruce W Birren; Yuriy Fofanov; John Boos; William D Wheaton; Christiane Honisch; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

4.  Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.

Authors:  Élodie Pastural; Shelly A McNeil; Donna MacKinnon-Cameron; Lingyun Ye; Joanne M Langley; Robert Stewart; Luis H Martin; Gregory J Hurley; Sanaz Salehi; Thomas A Penfound; Scott Halperin; James B Dale
Journal:  Vaccine       Date:  2019-12-13       Impact factor: 3.641

5.  Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance.

Authors:  Mark R Davies; Matthew T Holden; Paul Coupland; Jonathan H K Chen; Carola Venturini; Timothy C Barnett; Nouri L Ben Zakour; Herman Tse; Gordon Dougan; Kwok-Yung Yuen; Mark J Walker
Journal:  Nat Genet       Date:  2014-11-17       Impact factor: 38.330

6.  Prolonged and large outbreak of invasive group A Streptococcus disease within a nursing home: repeated intrafacility transmission of a single strain.

Authors:  S A Nanduri; B J Metcalf; M A Arwady; C Edens; M A Lavin; J Morgan; W Clegg; A Beron; J P Albertson; R Link-Gelles; A Ogundimu; J Gold; D Jackson; S Chochua; N Stone; C Van Beneden; K Fleming-Dutra; B Beall
Journal:  Clin Microbiol Infect       Date:  2018-05-18       Impact factor: 8.067

7.  Full-genome dissection of an epidemic of severe invasive disease caused by a hypervirulent, recently emerged clone of group A Streptococcus.

Authors:  Nahuel Fittipaldi; Stephen B Beres; Randall J Olsen; Vivek Kapur; Patrick R Shea; M Ebru Watkins; Concepcion C Cantu; Daniel R Laucirica; Leslie Jenkins; Anthony R Flores; Marguerite Lovgren; Carmen Ardanuy; Josefina Liñares; Donald E Low; Gregory J Tyrrell; James M Musser
Journal:  Am J Pathol       Date:  2012-02-11       Impact factor: 4.307

8.  Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.

Authors:  J C Levin; M R Wessels
Journal:  Mol Microbiol       Date:  1998-10       Impact factor: 3.501

9.  Genomic sequence investigation Streptococcus pyogenes clusters in England (2010-2015).

Authors:  J M Coelho; G Kapatai; A Jironkin; A Al-Shahib; R Daniel; C Dhami; A M Laranjeira; T Chambers; S Phillips; R Tewolde; A Underwood; V J Chalker
Journal:  Clin Microbiol Infect       Date:  2018-04-24       Impact factor: 8.067

10.  Multistate, Population-Based Distributions of Candidate Vaccine Targets, Clonal Complexes, and Resistance Features of Invasive Group B Streptococci Within the United States, 2015-2017.

Authors:  Lesley McGee; Sopio Chochua; Zhongya Li; Saundra Mathis; Joy Rivers; Benjamin Metcalf; Alison Ryan; Nisha Alden; Monica M Farley; Lee H Harrison; Paula Snippes Vagnone; Ruth Lynfield; Chad Smelser; Alison Muse; Ann R Thomas; Stephanie Schrag; Bernard W Beall
Journal:  Clin Infect Dis       Date:  2021-03-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.